UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000016904 |
|---|---|
| Receipt number | R000019620 |
| Scientific Title | A phase II study of erlotinib plus bevacizumab in chemo-naive patients aged 75 or older with advanced non-squamous non-small-cell lung cancer harboring sensitive EGFR gene mutations(HSR1501) |
| Date of disclosure of the study information | 2015/03/24 |
| Last modified on | 2020/08/25 10:24:09 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/03/24 22:44:30 | ||
| 2 | Update | 2016/09/24 07:16:18 | Name of primary person or sponsor Institute Department Organization Organization Division |
|
| 3 | Update | 2020/08/25 10:13:49 | UMIN ID1 |
|
| 4 | Update | 2020/08/25 10:17:48 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 5 | Update | 2020/08/25 10:24:09 | Recruitment status Date of IRB Last follow-up date |
